Metastatic melanoma treated with combined immunotherapy: a direct question?

In patients affected by metastatic melanoma (BRAF mutated) that were previously treated with target terapy (dabrafenib 75mg x 3 / day; trametinib 2mg / day) is it recommended to be treated with...

23 April 2019 6,155 5 View